Prognostic value of KRAS and BRAF mutations in curatively resected colorectal cancer

doi:10.3748/wjg.v21.i4.1275

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8502)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

711

WORD

269

HTML

4777

Figures (1-2)

156

Tables (1-4)

123

Sum=6036

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1167

Download

1299

Sum=2466

Jan 28, 2015 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (58)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Jan 28, 2015; 21(4): 1275-1283
Published online Jan 28, 2015. doi: 10.3748/wjg.v21.i4.1275

Open in New Tab Full Size Figure Download Figure

Figure 1 Kaplan-Meier curves for disease-free survival and overall survival according to KRAS or BRAF status. A: Disease-free survival (DFS) according to KRAS status; B: Overall survival (OS) according to KRAS status; C: DFS according to BRAF status; D: OS according to BRAF status.

Open in New Tab Full Size Figure Download Figure

Figure 2 Stratified analysis of KRAS or BRAF status and overall survival. Loge [adjusted hazard ratio (HR)] and 95%CI for BRAF and KRAS mutant tumors (vs wild-type tumors) in various strata are shown. A: KRAS mutant tumors; B: BRAF mutant tumors.

Citation: Kadowaki S, Kakuta M, Takahashi S, Takahashi A, Arai Y, Nishimura Y, Yatsuoka T, Ooki A, Yamaguchi K, Matsuo K, Muro K, Akagi K. Prognostic value of KRAS and BRAF mutations in curatively resected colorectal cancer. World J Gastroenterol 2015; 21(4): 1275-1283
URL: https://www.wjgnet.com/1007-9327/full/v21/i4/1275.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i4.1275